Sunshine Biopharma

SBFM

Drug Manufacturers - Specialty & Generic · Healthcare

Exchange

NASDAQ Capital Market

Winston Score

Winston is worried

Weak fundamentals across most pillars.

Data as of Aug 23, 2026 · filings through Jun 30, 2026

How the score breaks down

Quality

Weak

Growth

Good

Cash Flow

Weak

Stability

Data not available

Valuation

Data not available

Track this stock — start free trial

Winston Score History

The full picture

Sunshine Biopharma is a small pharmaceutical company focused on developing and selling cancer-fighting drugs and other medicines. Its main product is Adva-27a, an experimental compound targeting multiple types of cancer, and it also sells generic pharmaceutical products to generate near-term revenue. The company serves patients and healthcare providers, primarily in North America.

Sunshine Biopharma makes money by selling generic drugs while simultaneously spending on research to develop its own proprietary treatments. It is a very small company with a market cap under $100 million, and it operates at a loss, meaning it spends more than it earns right now. The biggest risk the company faces is running out of cash before it can get its experimental cancer drugs approved by regulators — a common and serious challenge for early-stage drug developers.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-1.6% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+98.5% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

0.5%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

~4 years

$14M cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

$14M cash & investments at current burn rate

Revenue declining

Sunshine Biopharma's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

26.2%

Modest — 26.2% gross margin

Profit after running costs

Operating Margin

-17.4%

Losing money on operations — -17.4%

Return on the money invested

ROCE

-18.9%

Weak — -18.9% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

-2.7%

Shrinking sales (-2.7% YoY)

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

8/8 quarters

Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

—

Data not available

Spare cash per sale

FCF Margin

-17.4%

Burning cash (-17.4%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial